Projects per year
Abstract
Background: Islet-specific autoantibodies predate and predict the onset of type 1 diabetes and can be used to screen for presymptomatic disease. Dried blood spots (DBS) offer a convenient and reliable method for community-based capillary sampling requiring low blood volumes compared to venous collection. We aimed to verify the use of DBS for detecting autoantibodies by the ElisaRSR (3-screen) multiplex assay compared to venous sampling and also explore the acceptability of DBS sampling.
Methods: Paired serum and DBS samples were collected from healthy controls (HC) and individuals with type 1 diabetes on insulin. Validation and verification of a 3-screen Islet cell autoantibody (IA-2A, GADA and ZnT8A) ELISA assay was undertaken for both matrices and compared. Perceived acceptability of DBS testing was explored via semi-structured interviews with parents and professional stakeholders.
Results: Temporally paired serum and DBS samples were collected for 101 individuals with type 1 diabetes (aged 7–73 years) and 22 HC (aged 18–60 years). Performance characteristics were similar for serum and DBS; sensitivity for serum was 86% compared to 89% for DBS and a specificity of 97% for serum compared to 100% for DBS. Parents (n = 38) and stakeholders (n = 25) thought DBS testing offered a minimally invasive, convenient screening test. Parents emphasised choice of screening location, including home and community settings.
Conclusions: DBS sampling can be used as an alternative to serum for use with the 3-screen assay for general population type 1 diabetes autoantibody screening. DBS sampling appears acceptable to parents and stakeholders.
| Original language | English |
|---|---|
| Article number | e70071 |
| Journal | Diabetic Medicine |
| Early online date | 19 May 2025 |
| DOIs | |
| Publication status | E-pub ahead of print - 19 May 2025 |
Bibliographical note
Copyright:© 2025 The Author(s). Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- autoantibodies
- disease prediction
- GADA
- IA-2A
- screening
- type 1 diabetes
- ZnT8A
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Endocrinology
Fingerprint
Dive into the research topics of 'Establishing the performance and acceptability of dried blood spot sampling to screen for islet-specific autoantibodies'. Together they form a unique fingerprint.Projects
- 1 Finished
-
Exploring the acceptability and feasibility of early surveillance for autoimmune diabetes (ELSA)
Barrett, T. (Co-Investigator), Shukla, D. (Researcher), Narendran, P. (Principal Investigator) & Greenfield, S. (Co-Investigator)
NIHR CENTRAL COMMISSIONING FACILITY
1/11/21 → 30/11/23
Project: Other Government Departments
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver